CA1062717A - Les 1-aryloxy-2-hydroxy-3-alkynylaminopropanes et procede pour leur production - Google Patents

Les 1-aryloxy-2-hydroxy-3-alkynylaminopropanes et procede pour leur production

Info

Publication number
CA1062717A
CA1062717A CA193,683A CA193683A CA1062717A CA 1062717 A CA1062717 A CA 1062717A CA 193683 A CA193683 A CA 193683A CA 1062717 A CA1062717 A CA 1062717A
Authority
CA
Canada
Prior art keywords
group
carbon atoms
formula
compounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA193,683A
Other languages
English (en)
Other versions
CA193683S (en
Inventor
Herbert Koppe
Werner Kummer
Helmut Stahle
Gojko Muacevic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2309887A external-priority patent/DE2309887C2/de
Priority claimed from DE19742403809 external-priority patent/DE2403809C2/de
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of CA1062717A publication Critical patent/CA1062717A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA193,683A 1973-02-28 1974-02-27 Les 1-aryloxy-2-hydroxy-3-alkynylaminopropanes et procede pour leur production Expired CA1062717A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2309887A DE2309887C2 (de) 1973-02-28 1973-02-28 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
DE19742403809 DE2403809C2 (de) 1974-01-26 1974-01-26 1-Aryloxy-2-hydroxy-3-alkinylaminopropane und Verfahren zu ihrer Herstellung und pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
CA1062717A true CA1062717A (fr) 1979-09-18

Family

ID=25764753

Family Applications (1)

Application Number Title Priority Date Filing Date
CA193,683A Expired CA1062717A (fr) 1973-02-28 1974-02-27 Les 1-aryloxy-2-hydroxy-3-alkynylaminopropanes et procede pour leur production

Country Status (24)

Country Link
US (1) US3925446A (fr)
JP (1) JPS594417B2 (fr)
AT (1) AT330150B (fr)
BG (7) BG20564A3 (fr)
CA (1) CA1062717A (fr)
CH (7) CH605690A5 (fr)
CS (1) CS186263B2 (fr)
DD (1) DD110652A5 (fr)
DK (1) DK143128C (fr)
ES (7) ES423466A1 (fr)
FI (1) FI62054C (fr)
FR (1) FR2218900B1 (fr)
GB (1) GB1450287A (fr)
HU (1) HU168598B (fr)
IE (1) IE39482B1 (fr)
IL (1) IL44301A (fr)
MX (2) MX4592E (fr)
NL (1) NL169733C (fr)
NO (1) NO138062C (fr)
PH (1) PH9722A (fr)
PL (2) PL91560B1 (fr)
SE (1) SE411897B (fr)
SU (1) SU793381A3 (fr)
YU (2) YU50074A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
US4078146A (en) * 1972-07-06 1978-03-07 Aktiebolaget Hassle Phenoxy propanolamines
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3009036A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung
DE3009047A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
DE3248835A1 (de) * 1981-06-23 1983-06-30 American Hospital Supply Corp Zusammensetzungen fuer die behandlung von glaukom
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
DE3133719A1 (de) * 1981-08-26 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-aryloxy-3-alkinylamino-2-propanole und verfahren zu ihrer herstellung
JPH02130007U (fr) * 1989-03-31 1990-10-26
AP2006003700A0 (en) * 2004-02-13 2006-08-31 Warner Lambert Co Androgen receptor modulators
JP5838114B2 (ja) 2012-04-02 2015-12-24 株式会社リガク X線トポグラフィ装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
GB1199037A (en) * 1967-09-27 1970-07-15 Ici Ltd Alkanolamine Derivatives
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes

Also Published As

Publication number Publication date
IE39482L (en) 1974-08-28
DK143128C (da) 1981-11-16
ES423466A1 (es) 1977-01-16
ES436316A1 (es) 1977-01-01
HU168598B (fr) 1976-06-28
GB1450287A (en) 1976-09-22
ES436311A1 (es) 1977-01-01
IE39482B1 (en) 1978-10-25
MX4588E (es) 1982-06-25
YU50074A (en) 1982-06-30
JPS594417B2 (ja) 1984-01-30
NL169733B (nl) 1982-03-16
FI62054B (fi) 1982-07-30
NO740670L (no) 1974-08-29
CH605639A5 (fr) 1978-10-13
AT330150B (de) 1976-06-10
BG20566A3 (bg) 1975-12-05
NO138062C (no) 1978-06-21
CH605691A5 (fr) 1978-10-13
NL7402704A (fr) 1974-08-30
CH605638A5 (fr) 1978-10-13
IL44301A (en) 1977-03-31
NO138062B (no) 1978-03-13
FI62054C (fi) 1982-11-10
PL91560B1 (fr) 1977-03-31
BG21208A3 (bg) 1976-03-20
ES436314A1 (es) 1977-01-01
JPS5024232A (fr) 1975-03-15
CS186263B2 (en) 1978-11-30
SU793381A3 (ru) 1980-12-30
PL93591B1 (fr) 1977-06-30
BG20564A3 (bg) 1975-12-05
BG21394A3 (bg) 1976-05-20
US3925446A (en) 1975-12-09
SE411897B (sv) 1980-02-11
BG20335A3 (bg) 1975-11-05
YU109580A (en) 1982-06-30
ES436313A1 (es) 1977-01-01
PH9722A (en) 1976-02-27
AU6606574A (en) 1975-08-28
ES436315A1 (es) 1977-01-01
BG20334A3 (bg) 1975-11-05
CH605637A5 (fr) 1978-10-13
ES436312A1 (es) 1977-01-01
FR2218900A1 (fr) 1974-09-20
CH605690A5 (fr) 1978-10-13
CH605689A5 (fr) 1978-10-13
IL44301A0 (en) 1974-06-30
DK143128B (da) 1981-06-29
NL169733C (nl) 1982-08-16
MX4592E (es) 1982-06-25
BG20565A3 (bg) 1975-12-05
FR2218900B1 (fr) 1978-01-06
CH605636A5 (fr) 1978-10-13
ATA104774A (de) 1975-09-15
DD110652A5 (de) 1975-01-05

Similar Documents

Publication Publication Date Title
CA1062717A (fr) Les 1-aryloxy-2-hydroxy-3-alkynylaminopropanes et procede pour leur production
CA1101859A (fr) Procedes d'obtention de 1-aryloxy-2-hydroxy-3- alkyleneaminopropanes
KR850000021B1 (ko) 3-아미노프로판-1,2-디올 유도체의 제조방법
US4146638A (en) N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
FR2722788A1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
US4490369A (en) Benzazepine derivatives, their pharmaceutical compositions and method of use
JPS6215546B2 (fr)
IE42119B1 (en) Aralkylamine derivatives
US4940780A (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
EP0008645B1 (fr) Alcoxyphénylpyrrolidones, procédé pour leur préparation et médicaments les contenant
US4363808A (en) N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
JPS6130573A (ja) 置換フエニルピペラジニル―プロパノール及びその製造方法
US4000193A (en) Pharmacologically active compounds
DE1940566A1 (de) 1-(2-Nitrilophenoxy)-2-hydroxy-3-aethylaminopropan und dessen Salze
CA1146575A (fr) Procede de fabrication de nouveaux derives de 2-aminoethanol
US4000192A (en) Pharmacologically active compounds
CA1246083A (fr) Ethanolamines
US4084002A (en) Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US4016202A (en) 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof
CA1147751A (fr) 1-aryloxy-3-alkylamino-2-propanols, et methode pour les preparer
US4101579A (en) Phenethanolamine ethers
US3954776A (en) 1-[Methylated piperidino(and pyrrolidin-1-yl)]-3-(substituted phenoxy)-2propanols
DE2309887C2 (de) 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4016286A (en) Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and their use as adrenolytics and hypotensives
US4434174A (en) Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines